Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2.
Zak, M., Hurley, C.A., Ward, S.I., Bergeron, P., Barrett, K., Balazs, M., Blair, W.S., Bull, R., Chakravarty, P., Chang, C., Crackett, P., Deshmukh, G., Devoss, J., Dragovich, P.S., Eigenbrot, C., Ellwood, C., Gaines, S., Ghilardi, N., Gibbons, P., Gradl, S., Gribling, P., Hamman, C., Harstad, E., Hewitt, P., Johnson, A., Johnson, T., Kenny, J.R., Koehler, M.F., Bir Kohli, P., Labadie, S., Lee, W.P., Liao, J., Liimatta, M., Mendonca, R., Narukulla, R., Pulk, R., Reeve, A., Savage, S., Shia, S., Steffek, M., Ubhayakar, S., van Abbema, A., Aliagas, I., Avitabile-Woo, B., Xiao, Y., Yang, J., Kulagowski, J.J.(2013) J Med Chem 56: 4764-4785
- PubMed: 23659214 
- DOI: https://doi.org/10.1021/jm4004895
- Primary Citation of Related Structures:  
4IVA, 4IVB, 4IVC, 4IVD - PubMed Abstract: 
Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1 inhibitors. X-ray structures of a C-2 hydroxyethyl analogue in complex with both JAK1 and JAK2 revealed differential ligand/protein interactions between the two isoforms and offered an explanation for the observed selectivity ...